Displaying 1 - 10 of 10
General Hepatology
5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View
Metabolism, Alcohol & Toxicity
1

Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" - EASL Congress 2023

View
General Hepatology
5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View
General Hepatology
5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View
General Hepatology
5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View
General Hepatology
5

Grifols: "The burden of hepatic encephalopathy and albumin as potential approach" - EASL Congress 2023

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Cirrhosis & Complications
4

Grifols: Albumin: a disease-modifying agent in decompensated cirrhosis - Digital ILC 2020

View
Displaying 1 - 10 of 10